Showing results (1-10 of 270) with videos related to
Sort By:
Pageof 27
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2009
Romiplostim: a second-generation thrombopoietin agonistClaudia S Cohn, James B BusselBritish Journal of Haematology|November 21, 2022
Why should intramuscular anti-D be different from intravenous anti-D?James B BusselBest Practice & Research. Clinical Haematology|December 3, 2014
The new thrombopoietic agenda: impact on leukemias and MDSJames B BusselAmerican Journal of Perinatology|January 3, 2004
Fetal and neonatal cytopenias: what have we learned?James B BusselHematology/Oncology Clinics of North America|November 26, 2009
Traditional and new approaches to the management of immune thrombocytopenia: issues of when and who to treatJames B BusselSeminars in Hematology|February 28, 2009
Therapeutic approaches to secondary immune thrombocytopenic purpuraJames B BusselThe Journal of Clinical Investigation|July 26, 2008
Fc receptors in immune thrombocytopenias: a target for immunomodulation?Bethan Psaila, James B BusselClinical Advances in Hematology & Oncology : H&O|February 14, 2015
Review of fetal and neonatal immune cytopeniasSharon Lewin, James B BusselBritish Journal of Haematology|October 13, 2023
Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonistsAmihai Rottenstreich, James B BusselBritish Journal of Haematology|October 17, 2024
What is the best second-line treatment for immune thrombocytopenia?Matthieu Mahévas, James B BusselPageof 27